G Griffin, S Shenoi, GC Hughes - Best Practice & Research Clinical …, 2020 - Elsevier
Hemophagocytic lymphohistiocytosis (HLH) is a rare, life-threatening state of immune hyperactivation that arises in the setting of genetic mutations and infectious, inflammatory, or …
E Raschi, M Gatti, F Gelsomino, A Ardizzoni… - Targeted Oncology, 2020 - Springer
The advent of immune checkpoint inhibitors (ICIs) caused a paradigm shift both in drug development and clinical practice; however, by virtue of their mechanism of action, the …
Haemophagocytic lymphohistiocytosis (HLH) is an inflammatory syndrome that can occur with cancer (malignancy-associated HLH) or with immune-activating therapies for cancer …
L Diaz, B Jauzelon, AC Dillies, C Le Souder… - Journal of Clinical …, 2023 - mdpi.com
Background: Acquired hemophagocytic lymphohistiocytosis (HLH) is a rare but potentially fatal condition characterized by hyperactivation of macrophages and cytotoxic lymphocytes …
X Sun, J Lyu, M Yang, Y Lin, K Wu, K Liu, A Li… - Annals of Surgical …, 2024 - Springer
Background This study reports the 2-year outcomes and biomarker analysis results of patients with locally advanced gastric and gastroesophageal junction (G/GEJ) …
A Zoref-Lorenz, M Ellis, MB Jordan - Hematology, 2023 - ashpublications.org
Hemophagocytic lymphohistiocytosis (HLH) is one of the life-threatening emergencies that a hematologist may be called upon to diagnose and manage. It is a hyperinflammatory …
Simple Summary Although rare, hemophagocytic lymphohistiocytosis (HLH), a syndrome of severe, dysregulated inflammation, is associated with poor survival when it occurs in …
P Rajapakse, H Andanamala - World Journal of Oncology, 2022 - ncbi.nlm.nih.gov
Hemophagocytic lymphohistiocytosis (HLH) is a fatal systemic inflammatory syndrome. HLH has been reported as a rare immune-related adverse event (irAE) in patients receiving …